Description: China Regenerative Medicine International Limited, an investment holding company, produces and sells healthcare products and services. The company offers health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services comprising non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate repairing services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
Home Page: www.crmi.hk
Miramar Tower
Tsim Sha Tsui,
Hong Kong
Phone:
852 3918 9000
Officers
| Name | Title |
|---|---|
| Mr. Chuang Wang | CEO, Exec. Chairman & Compliance Officer |
| Mr. Po Tin Wong | Chief Financial Officer |
| Dr. Xiaohu Sun | Chief Operating Officer |
| Dr. Jinnan Zhang | Chief Technology Officer |
| Mr. Wing Nin Ip | Legal Counsel |
| Dr. Zhanfeng Cui Freng | Chairman of Stem Cell Division & Director of University of Oxford Tissue Engineering Centre |
| Mr. Wun Fat Khoo | Company Sec. |
Exchange: HK
Country: HK : Hong Kong
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 11 |
| Price-to-Book MRQ: | 3.0568 |
| Price-to-Sales TTM: | 1.74 |
| IPO Date: | 2001-07-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 18 |